Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
1.690
-0.410 (-19.52%)
Nov 16, 2026, 3:37 PM EST - Market open

Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $10.56 million. The enterprise value is -$8.63 million.

Market Cap10.56M
Enterprise Value -8.63M

Important Dates

The last earnings date was Friday, November 6, 2026, before market open.

Earnings Date Nov 6, 2026
Ex-Dividend Date n/a

Share Statistics

ALGS has 6.25 million shares outstanding. The number of shares has increased by 17.65% in one year.

Current Share Class 5.45M
Shares Outstanding 6.25M
Shares Change (YoY) +17.65%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) 2.22%
Owned by Institutions (%) 18.29%
Float 3.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.31
Forward PS 4.19
PB Ratio 1.16
P/TBV Ratio 0.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.05.

Current Ratio 1.77
Quick Ratio 1.59
Debt / Equity 1.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -159.46% and return on invested capital (ROIC) is -89.66%.

Return on Equity (ROE) -159.46%
Return on Assets (ROA) -57.76%
Return on Invested Capital (ROIC) -89.66%
Return on Capital Employed (ROCE) -262.87%
Weighted Average Cost of Capital (WACC) 8.25%
Revenue Per Employee $410,317
Profits Per Employee -$808,354
Employee Count82
Asset Turnover 0.43
Inventory Turnover n/a

Taxes

In the past 12 months, ALGS has paid $3.48 million in taxes.

Income Tax 3.48M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.72% in the last 52 weeks. The beta is 2.43, so ALGS's price volatility has been higher than the market average.

Beta (5Y) 2.43
52-Week Price Change -73.72%
50-Day Moving Average 4.85
200-Day Moving Average 5.98
Relative Strength Index (RSI) 18.80
Average Volume (20 Days) 65,120

Short Selling Information

The latest short interest is 677,218, so 10.84% of the outstanding shares have been sold short.

Short Interest 677,218
Short Previous Month 707,471
Short % of Shares Out 10.84%
Short % of Float 20.15%
Short Ratio (days to cover) 17.16

Income Statement

In the last 12 months, ALGS had revenue of $33.65 million and -$66.29 million in losses. Loss per share was -$6.37.

Revenue33.65M
Gross Profit -49.69M
Operating Income -72.52M
Pretax Income -62.80M
Net Income -66.29M
EBITDA -71.41M
EBIT -72.52M
Loss Per Share -$6.37
Full Income Statement

Balance Sheet

The company has $31.09 million in cash and $11.90 million in debt, with a net cash position of $19.19 million or $3.07 per share.

Cash & Cash Equivalents 31.09M
Total Debt 11.90M
Net Cash 19.19M
Net Cash Per Share $3.07
Equity (Book Value) 11.31M
Book Value Per Share 1.81
Working Capital 15.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.37 million and capital expenditures -$289,000, giving a free cash flow of -$68.66 million.

Operating Cash Flow -68.37M
Capital Expenditures -289,000
Depreciation & Amortization 1.11M
Net Borrowing -89,000
Free Cash Flow -68.66M
FCF Per Share -$10.99
Full Cash Flow Statement

Margins

Gross margin is -147.67%, with operating and profit margins of -215.55% and -197.01%.

Gross Margin -147.67%
Operating Margin -215.55%
Pretax Margin -186.65%
Profit Margin -197.01%
EBITDA Margin -212.25%
EBIT Margin -215.55%
FCF Margin n/a

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -17.65%
Shareholder Yield -17.65%
Earnings Yield -376.82%
FCF Yield -654.07%

Analyst Forecast

The average price target for ALGS is $36.88, which is 2,082.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target $36.88
Price Target Difference 2,082.25%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (3Y) 34.78%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on August 19, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date Aug 19, 2024
Split Type Reverse
Split Ratio 1:25

Scores

ALGS has an Altman Z-Score of -23.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -23.66
Piotroski F-Score 2